Reply
William Sievert, Gregory J. Dore, Stuart K. Roberts, On behalf of the CHARIOT Study Group – 25 February 2011
Role of the coinhibitory receptor cytotoxic T lymphocyte antigen‐4 on apoptosis‐Prone CD8 T cells in persistent hepatitis B virus infection
Anna Schurich, Pooja Khanna, A. Ross Lopes, Ki Jun Han, Dimitra Peppa, Lorenzo Micco, Gaia Nebbia, Patrick T.F. Kennedy, Anna‐Maria Geretti, Geoffrey Dusheiko, Mala K. Maini – 25 February 2011 – An excess of coinhibitory signals has been proposed to drive the T‐cell exhaustion characteristic of persistent viral infections. In this study we examined the contribution of the coinhibitory receptor cytotoxic T lymphocyte antigen‐4 (CTLA‐4) to CD8 T cell tolerance in chronic hepatitis B virus (HBV) infection (CHB).
Management of alcohol dependence in transplant candidates: We are far away from the objective line
Philippe Mathurin, Florent Ehrhard – 25 February 2011
Patatin‐like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma
Stefano Ginanni Corradini, Maria Antonella Burza, Antonio Molinaro, Stefano Romeo – 23 February 2011
Metabolic syndrome and nonalcoholic steatohepatitis recurrence after liver transplantation in children
Valerio Nobili, Anna Alisi, Jean de Ville de Goyet – 23 February 2011
Significance of isolated hepatic veno‐occlusive disease/sinusoidal obstruction syndrome after liver transplantation
Mylène Sebagh, Daniel Azoulay, Bruno Roche, Emir Hoti, Vincent Karam, Elina Teicher, Laurence Bonhomme‐Faivre, Faouzi Saliba, Jean‐Charles Duclos‐Vallée, Didier Samuel – 23 February 2011 – After liver transplantation (LT), hepatic veno‐occlusive disease (VOD), which is also known as sinusoidal obstruction syndrome (SOS), has been reported initially in relation to azathioprine use and subsequently in relation to acute rejection (AR). Isolated veno‐occlusive disease (iVOD)/SOS raises some questions about its significance and especially its treatment.
Incidence of primary sclerosing cholangitis: A systematic review and meta‐analysis
Natalie A. Molodecky, Hashim Kareemi, Rohan Parab, Herman W. Barkema, Hude Quan, Robert P. Myers, Gilaad G. Kaplan – 23 February 2011 – Incidence studies of primary sclerosing cholangitis (PSC) are important for describing the disease's burden and for shedding light on the disease's etiology. The purposes of this study were to conduct a systematic review of the incidence studies of PSC with a meta‐analysis and to investigate possible geographic variations and temporal trends in the incidence of the disease.
Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children
James R. Rodrigue, William Balistreri, Barbara Haber, Maureen M. Jonas, Parvathi Mohan, Jean P. Molleston, Karen F. Murray, Michael R. Narkewicz, Philip Rosenthal, Lesley J. Smith, Steven J. Lobritto, Kathleen B. Schwarz, Patricia R. Robuck, Bruce Barton, Regino P. González‐Peralta – 23 February 2011 – The aim of this study was to prospectively assess the quality of life (QOL), behavioral/emotional functioning, and cognitive status of children undergoing treatment for hepatitis C virus (HCV) infection.
Immune response to pandemic H1N1 2009 influenza a vaccination in pediatric liver transplant recipients
Wolfram Haller, Jim Buttery, Karen Laurie, Kathe Beyerle, Winita Hardikar, George Alex – 23 February 2011 – After the announcement of a worldwide pandemic in June 2009, a single dose of a monovalent pandemic H1N1 2009 influenza A (pH1N1/09) vaccine was advocated for all Australians who were 10 years and older because of excellent immunogenicity trial results for healthy children and adults. Immunocompromised patients have previously been shown to have lower seroconversion rates after routine vaccinations.